269 related articles for article (PubMed ID: 24935257)
1. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Lepore M; de Lalla C; Gundimeda SR; Gsellinger H; Consonni M; Garavaglia C; Sansano S; Piccolo F; Scelfo A; Häussinger D; Montagna D; Locatelli F; Bonini C; Bondanza A; Forcina A; Li Z; Ni G; Ciceri F; Jenö P; Xia C; Mori L; Dellabona P; Casorati G; De Libero G
J Exp Med; 2014 Jun; 211(7):1363-77. PubMed ID: 24935257
[TBL] [Abstract][Full Text] [Related]
2. Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.
Consonni M; Garavaglia C; Grilli A; de Lalla C; Mancino A; Mori L; De Libero G; Montagna D; Casucci M; Serafini M; Bonini C; Häussinger D; Ciceri F; Bernardi M; Mastaglio S; Bicciato S; Dellabona P; Casorati G
Nat Commun; 2021 Aug; 12(1):4844. PubMed ID: 34381053
[TBL] [Abstract][Full Text] [Related]
3. T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids.
Wun KS; Reijneveld JF; Cheng TY; Ladell K; Uldrich AP; Le Nours J; Miners KL; McLaren JE; Grant EJ; Haigh OL; Watkins TS; Suliman S; Iwany S; Jimenez J; Calderon R; Tamara KL; Leon SR; Murray MB; Mayfield JA; Altman JD; Purcell AW; Miles JJ; Godfrey DI; Gras S; Price DA; Van Rhijn I; Moody DB; Rossjohn J
Nat Immunol; 2018 Apr; 19(4):397-406. PubMed ID: 29531339
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Le Dieu R; Taussig DC; Ramsay AG; Mitter R; Miraki-Moud F; Fatah R; Lee AM; Lister TA; Gribben JG
Blood; 2009 Oct; 114(18):3909-16. PubMed ID: 19710498
[TBL] [Abstract][Full Text] [Related]
5. [Hybrid leukemia among acute childhood leukemias].
Koehler M; Bubała H
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):347-9. PubMed ID: 1437751
[TBL] [Abstract][Full Text] [Related]
6. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
7. CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens.
Ly D; Kasmar AG; Cheng TY; de Jong A; Huang S; Roy S; Bhatt A; van Summeren RP; Altman JD; Jacobs WR; Adams EJ; Minnaard AJ; Porcelli SA; Moody DB
J Exp Med; 2013 Apr; 210(4):729-41. PubMed ID: 23530121
[TBL] [Abstract][Full Text] [Related]
8. Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.
Adams EJ
Mol Immunol; 2013 Sep; 55(2):182-5. PubMed ID: 23127489
[TBL] [Abstract][Full Text] [Related]
9. Identification of self-lipids presented by CD1c and CD1d proteins.
Haig NA; Guan Z; Li D; McMichael A; Raetz CR; Xu XN
J Biol Chem; 2011 Oct; 286(43):37692-701. PubMed ID: 21900247
[TBL] [Abstract][Full Text] [Related]
10. Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells.
Mansour S; Tocheva AS; Cave-Ayland C; Machelett MM; Sander B; Lissin NM; Molloy PE; Baird MS; Stübs G; Schröder NW; Schumann RR; Rademann J; Postle AD; Jakobsen BK; Marshall BG; Gosain R; Elkington PT; Elliott T; Skylaris CK; Essex JW; Tews I; Gadola SD
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1266-75. PubMed ID: 26884207
[TBL] [Abstract][Full Text] [Related]
11. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
12. CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes.
Russano AM; Bassotti G; Agea E; Bistoni O; Mazzocchi A; Morelli A; Porcelli SA; Spinozzi F
J Immunol; 2007 Mar; 178(6):3620-6. PubMed ID: 17339459
[TBL] [Abstract][Full Text] [Related]
13. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.
Adams EJ
Curr Opin Immunol; 2014 Feb; 26():1-6. PubMed ID: 24556395
[TBL] [Abstract][Full Text] [Related]
14. Presentation of the same glycolipid by different CD1 molecules.
Shamshiev A; Gober HJ; Donda A; Mazorra Z; Mori L; De Libero G
J Exp Med; 2002 Apr; 195(8):1013-21. PubMed ID: 11956292
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
16. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
[TBL] [Abstract][Full Text] [Related]
17. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
18. CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity.
Pereira CS; Macedo MF
J Immunol Res; 2016; 2016():2876275. PubMed ID: 28070524
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD200 on AML blasts directly suppresses memory T-cell function.
Coles SJ; Hills RK; Wang EC; Burnett AK; Man S; Darley RL; Tonks A
Leukemia; 2012 Sep; 26(9):2148-51. PubMed ID: 22430635
[No Abstract] [Full Text] [Related]
20. Four pathways of CD1 antigen presentation to T cells.
Moody DB; Cotton RN
Curr Opin Immunol; 2017 Jun; 46():127-133. PubMed ID: 28756303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
